SARCOPENIA AND FUNCTIONAL DECLINE: PATHOPHYSIOLOGY, PREVENTION AND THERAPY

REFERENCES

• Rosenberg IH. Summary comments. Am] Clin Nutr. 1989; 50: 1231–3.
   Web of Science ®Google Scholar
• Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997; 127: 990S–1S.
   PubMed Web of Science ®Google Scholar
• Morley JE. Editorial: The top 10 hot topics in aging. ] Gerontol A Biol Sci Med Sci. 2004; 59A: 24–33.
   Google Scholar
• Sehl ME, Yates FE. Kinetics of human aging: I. Rates of se-nescence between ages 30 and 70 years in healthy people.] Gerontol A Biol Sci Med Sci. 2001; 56: B198–208.
   Google Scholar
• Lexell J, Taylor CC, Sjostrom M.What is the cause of the age-ing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15-to 83-year-old men. ] Neurol Sci. 1988; 84: 275–94.
   PubMed Web of Science ®Google Scholar
• Marcell Ti. Review Article: Sarcopenia: Causes, Consequenc-es, and Preventions. J Gerontol A Biol Sci Med Sci. 2003; 58: M911–6.
   PubMed Web of Science ®Google Scholar
• Frontera WR, Hughes VA, Lutz KJ, Evans WJ. A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women.' Appl Physiol. 1991; 71: 644–50.
   PubMed Web of Science ®Google Scholar
• Doherty TJ. Invited review: Aging and sarcopenia. JAppl Phys-iol. 2003; 95: 1717–27.
   Google Scholar
• Narici MV, Maganaris CN. Plasticity of the muscle-tendon complex with disuse and aging. Exerc Sport Sci Rev. 2007; 35: 126–34.
   PubMed Web of Science ®Google Scholar
• Aniansson A, Grimby G, Hedberg M. Compensatory muscle fiber hypertrophy in elderly men. J App! Physiol. 1992; 73: 812–6.
   Web of Science ®Google Scholar
• Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heyms-field SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Amen can journal of epidemiology. 1998; 147: 755–63.
   PubMed Web of Science ®Google Scholar
• Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with func-tional impairment and physical disability. ] Am Geriatr Soc. 2002; 50: 889–96.
   PubMed Web of Science ®Google Scholar
• Melton Li, 3rd, Khosla S, Crowson CS, O'Connor MK, O'Fallon WM, Riggs BL. Epidemiology of sarcopenia. ]Am Geriatr Soc. 2000; 48: 625–30.
   PubMed Web of Science ®Google Scholar
• Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard DL, Barrett-Connor E. Sarcopenia in elderly men and women: The Rancho Bernardo study. American Journal of Preventive Medicine. 2003; 25: 226–31.
   PubMed Web of Science ®Google Scholar
• Gallagher D, Ruts E, Visser M, Heshka S, Baumgartner RN, Wang J, et al. Weight stability masks sarcopenia in elderly men and women. Am J Physiol Endocrinol Metab. 2000; 279: E366–75.
   PubMed Web of Science ®Google Scholar
• Estrada M, Kleppinger A, Judge JO, Walsh Si, Kuchel GA. Func-tional impact of relative versus absolute sarcopenia in healthy older women. ]Am Geriatr Soc. 2007; 55: 1712–9.
   PubMed Web of Science ®Google Scholar
• Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sar-copenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008; 18:388–95.
   PubMed Web of Science ®Google Scholar
• Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di lorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcope-nia. J Appl Physiol. 2003; 95: 1851–60.
   PubMed Web of Science ®Google Scholar
• Hurley MV, Rees J, Newham DJ. Quadriceps function, proprio-ceptive acuity and functional performance in healthy young, middle-aged and elderly subjects. Age Ageing. 1998; 27: 55–62.
   PubMed Web of Science ®Google Scholar
• Hortobagyi T, MizeRe C, Beam S, DeVita P. Old adults per-form activities of daily living near their maximal capabilities. J Gerontol A Biol Sci Med Sci. 2003; 58: M453–60.
   PubMed Web of Science ®Google Scholar
• Mets T, Bautmans I, Njemini R, Lambert M, Demanet C. The influence of celecoxib on muscle fatigue resistance and mo-bility in elderly patients with inflammation. Am] Geriatr Pharmacother. 2004; 2: 230–8.
   PubMedGoogle Scholar
• Bautmans I, Njemini R, Lambert M, Demanet C, Mets T. Cir-culating Acute Phase Mediators and Skeletal Muscle Perfor-mance in Hospitalized Geriatric Patients. ] Gerontol A Biol Sci Med Sci. 2005; 60: 361–7.
   PubMed Web of Science ®Google Scholar
• Hoenig H, Rubenstein LZ. Hospital-associated deconditioning and dysfunction. ]Am Geriatr Soc. 1991; 39:220–2.
   PubMed Web of Science ®Google Scholar
• WHO. Active Ageing: a policy framework. March 2009 [cited; Available from: http://whqlibdoc.whoint/hq/2002/WHO_NMH_NPH_02.8.pdf
   Google Scholar
• Bevolkingsvooruitzichten 1995–2025. In: Federaal Planbureau Brussel B, ed.: Nationaal I nstituut voor de Statistiek.
   Google Scholar
• Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory media-tors in the elderly. Exp Gerontol. 2004; 39:687–99.
   PubMed Web of Science ®Google Scholar
• Kushner I. C-reactive protein elevation can be caused by con-ditions other than inflammation and may reflect biologic ag-ing. Cleve Clin I Med. 2001; 68: 535–7.
   PubMed Web of Science ®Google Scholar
• Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study.] Gerontol A Biol Sci Med Sci. 2002; 57: M326–32.
   PubMed Web of Science ®Google Scholar
• Payette H, Roubenoff R, Jacques PF, Dinarello CA, Wilson PW, Abad LW, et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. JAm Geriatr Soc. 2003; 51: 1237–43.
   PubMed Web of Science ®Google Scholar
• Zanni F, Vescovini R, Biasini C, Fagnoni F, Zanlari L, Telera A, et al. Marked increase with age of type 1 cytokines within mem-ory and effector/cytotoxic CD8+ T cells in humans: a contri-bution to understand the relationship between inflammation and immunosenescence. Exp Gerontol. 2003; 38:981–7.
   PubMed Web of Science ®Google Scholar
• Trappe S, Gallagher P, Harber M, Carrithers J, Fluckey J, Trappe T. Single muscle fibre contractile properties in young and old men and women. ] Physiol. 2003; 552:47–58.
   PubMed Web of Science ®Google Scholar
• Kent-Braun JA, Ng AV, Young K. Skeletal muscle contractile and noncontractile components in young and older women and men. J Appl Physiol. 2000; 88:662–8.
   PubMed Web of Science ®Google Scholar
• Avery NC, Bailey AJ. Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: relevance to aging and exercise. Scanc J Med Sci Sports. 2005; 15: 231–40.
   PubMed Web of Science ®Google Scholar
• Hightower LE, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, et al. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2008.
   Google Scholar
• Vos MJ, Hageman J, Carra S, Kampinga HH. Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry. 2008; 47: 7001–11.
   PubMed Web of Science ®Google Scholar
• Lee CE, McArdle A, Griffiths RD. The role of hormones, cytok-ines and heat shock proteins during age-related muscle loss. Clinical nutrition (Edinburgh, Scotland). 2007; 26:524–34.
   PubMed Web of Science ®Google Scholar
• Njemini R, Bautmans I, Lambert M, Demanet C, Mets T. Heat shock proteins and chemokine/cytokine secretion profile in ageing and inflammation. Mech Ageing Dev. 2007; 128:450–4.
   Web of Science ®Google Scholar
• Njemini R, Lambert M, Demanet C, Kooijman R, Mets T. Basal and infection-induced levels of heat shock proteins in human aging. Biogerontology. 2007.
   Google Scholar
• Njemini R, Lambert M, Demanet C, Mets T. Heat shock pro-tein 32 in human peripheral blood mononuclear cells: effect of aging and inflammation. J Clin Immunol. 2005; 25: 405–17.
   Web of Science ®Google Scholar
• Njemini R, Lambert M, Demanet C, Mets T. The effect of aging and inflammation on heat shock protein 27 in human mono-cytes and lymphocytes. Exp Gerontol. 2006; 41: 312–9.
   Web of Science ®Google Scholar
• Njemini R, Abeele MV, Demanet C, Lambert M, Vandebosch S, Mets T. Age-related decrease in the inducibility of heat-shock protein 70 in human peripheral blood mononuclear cells. J Clin Immunol. 2002; 22: 195–205.
   Web of Science ®Google Scholar
• Njemini R, Demanet C, Mets T. Inflammatory status as an im-portant determinant of heat shock protein 70 serum concen-trations during aging. Biogerontology. 2004; 5: 31–8.
   PubMed Web of Science ®Google Scholar
• Bautmans I, Njemini R, Vasseur S, Chabert H, Moens L, De-manet C, et al. Biochemical changes in response to intensive resistance exercise training in the elderly. Gerontology. 2005; 51: 253–65.
   Google Scholar
• Delves PJ, Roitt IM. The immune system. Second of two parts. N Engl.] Med. 2000; 343: 108–17.
   PubMed Web of Science ®Google Scholar
• Mackinnon L. Exercise and immunology. Champaign, Illinois: Human Kinetics 1992.
   Google Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl.] Med. 1999; 340:448–54.
   PubMed Web of Science ®Google Scholar
• Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimu-lation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med. 1983; 308: 553–8.
   Google Scholar
• Kotler DP. Cachexia. Ann Intern Med. 2000; 133: 622–34.
   PubMed Web of Science ®Google Scholar
• Zoico E, Roubenoff R. The role of cytokines in regulating pro-tein metabolism and muscle function. Nutr Rev. 2002; 60:39–51.
   PubMed Web of Science ®Google Scholar
• Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med. 1996; 335: 1897–905.
   PubMed Web of Science ®Google Scholar
• Argiles JM, Alvarez B, Carbo N, Busquets S, Van Royen M, Lopez-Soriano FJ. The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting. Eur Cytokine Netw. 2000; 11: 552–9.
   Web of Science ®Google Scholar
• Montero-Odasso M, Duque G. Vitamin D in the aging muscu-loskeletal system: an authentic strength preserving hormone. Molecular Aspects of Medicine. 2005; 26: 203–19.
   PubMedGoogle Scholar
• Mets T. Calcium, vitamin D, and hip fractures. Incidence of falls may have decreased. Bmj. 1994; 309: 193.
   Web of Science ®Google Scholar
• Bietlot M, Demarest F, Tafforeau J, Van Oyen H. Gezondhe-idsenqueste 1997 en 2001. De gezondheid in Belgi6, zijn ge-meenschappen en gewesten. 2001 [ cited; Available from: http//www.iph.fgov.be/epidemio/epinl/index4.htm
   Google Scholar
• Hawkins SA, Wiswell RA, Marcell Ti. Exercise and the master athlete--a model of successful aging? J Gerontol A Biol Sci Med Sci. 2003; 58: 1009–11.
   PubMed Web of Science ®Google Scholar
• Wiswell RA, Hawkins SA, Jaque SV, Hyslop D, Constantino N, Tarpenning K, et al. Relationship between physiological loss, performance decrement, and age in master athletes. J Geron-tol A Biol Sci Med Sci. 2001; 56: M618–26.
   PubMed Web of Science ®Google Scholar
• Meltzer DE. Age dependence of Olympic weightlifting ability. Med Sci Sports Exerc. 1994; 26: 1053–67.
   PubMed Web of Science ®Google Scholar
• Klitgaard H, Mantoni M, Schiaffino S, Ausoni S, Gorza L, Lau-rent-Winter C, et al. Function, morphology and protein ex-pression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand. 1990; 140:41–54.
   PubMedGoogle Scholar
• Brown M. The master athlete. Orthopaedic Physical Therapy Clinics of North America. 1997; 6:253–66.
   Google Scholar
• Merkies IS, Schmitz PI, Samijn JP, Meche FG, Toyka KV, van Doomn PA. Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies. Muscle Nerve. 2000; 23: 1393–401.
   Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdi-ener J, et al. Frailty in Older Adults: Evidence for a Phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56: M146–57.
   PubMed Web of Science ®Google Scholar
• Syddall H, Cooper C, Martin F, Briggs R, Aihie Sayer A. Is grip strength a useful single marker of frailty? Age Ageing. 2003; 32: 650–6.
   PubMed Web of Science ®Google Scholar
• Avlund K, Vass M, Hendriksen C. Onset of mobility disability among community-dwelling old men and women. The role of tiredness in daily activities. Age Ageing. 2003; 32: 579–84.
   PubMed Web of Science ®Google Scholar
• Chen MK. The epidemiology of self-perceived fatigue among adults. Prey Med. 1986; 15: 74–81.
   PubMed Web of Science ®Google Scholar
• Liao S, Ferrell BA. Fatigue in an older population. JAm Geriatr Soc. 2000; 48:426–30.
   PubMed Web of Science ®Google Scholar
• Bautmans I, Mets T. A fatigue resistance test for elderly per-sons based on grip strength: reliability and comparison with healthy young subjects. Aging Clin Exp Res. 2005; 17: 217–22.
   Web of Science ®Google Scholar
• Bautmans I, Gorus E, Njemini R, Mets T. Handgrip performance in relation to self-perceived fatigue, physical functioning and circulating IL-6 in elderly persons without inflammation. BMC Geriatr. 2007; 7: 5.
   PubMedGoogle Scholar
• Bautmans I, Njemini R, Predom H, Lemper JC, Mets T. Muscle endurance in elderly nursing home residents is related to fatigue perception, mobility, and circulating tumor necrosis factor-alpha, interleukin-6, and heat shock protein 70. J Am Geriatr Soc. 2008; 56: 389–96.
   PubMed Web of Science ®Google Scholar
• Hurley BF, Roth SM. Strength training in the elderly: effects on risk factors for age-related diseases. Sports Med. 2000; 30: 249–68.
   PubMed Web of Science ®Google Scholar
• Latham NK, Bennett DA, Stretton CM, Anderson CS. System-atic review of progressive resistance strength training in older adults. J Gerontol A Biol Sci Med Sci. 2004; 59: M48–61.
   PubMed Web of Science ®Google Scholar
• Latham NK, Andersen-Ranberg K, Bennett DA, Stretton CM. Progressive resistance training for physical disability in older people (Cochrane Review). The Cochrane Library. 2003; 2.
   Google Scholar
• Williams GN, Higgins MJ, Lewek MD. Aging skeletal muscle: physiologic changes and the effects of training. Phys Ther. 2002; 82: 62–8.
   Web of Science ®Google Scholar
• Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, Evans WJ. High-intensity strength training in nonagenarians. Effects on skeletal muscle. Jama. 1990; 263: 3029–34.
   Google Scholar
• Roth SM, Ferrell RF, Hurley BF. Strength training for the pre-vention and treatment of sarcopenia. J Nutr Health Aging. 2000; 4: 143–55.
   PubMedGoogle Scholar
• Harridge SD, Kryger A, Stensgaard A. Knee extensor strength, activation, and size in very elderly people following strength training. Muscle Nerve. 1999; 22: 831–9.
   PubMed Web of Science ®Google Scholar
• Pyka G, Lindenberger E, Charette S, Marcus R. Muscle strength and fiber adaptations to a year-long resistance training pro-gram in elderly men and women. J Gerontol. 1994; 49: M22–7.
   PubMedGoogle Scholar
• Trappe S, Williamson D, Godard M, Porter D, Rowden G, Costill D. Effect of resistance training on single muscle fiber contrac-tile function in older men.J Appl Physiol. 2000; 89: 143–52.
   PubMed Web of Science ®Google Scholar
• Rydwik E, Frandin K, Akner G. Effects of physical training on physical performance in institutionalised elderly patients (70+) with multiple diagnoses. Age Ageing. 2004; 33: 13–23.
   PubMed Web of Science ®Google Scholar
• Bautmans I, Van Hees E, Lemper JC, Mets T. The feasibility of whole body vibration in institutionalised elderly persons and its influence on muscle performance, balance and mobility: a randomised controlled trial [ISRCTN62535013]. BMC Geriatr. 2005; 5:17.
   PubMedGoogle Scholar
• Thomas VS, Hageman PA. Can neuromuscular strength and function in people with dementia be rehabilitated using re-sistance-exercise training? Results from a preliminary inter-vention study. J Gerontol A Biol Sci Med Sci. 2003; 58: 746–51.
   PubMed Web of Science ®Google Scholar
• van den Ende CH, Breedveld FC, le Cessie S, Dijkmans BA, de Mug AW, Hazes JM. Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical Ann Rheum Dis. 2000; 59:615–21.
   Google Scholar
• Van Den Ende CH, Vliet Vlieland TP, Munneke M, Hazes JM. Dynamic exercise therapy for rheumatoid arthritis. Cochrane Database Syst Rev. 2000: CD000322.
   Google Scholar
• Rall LC, Meydani SN, Kehayias JJ, Dawson-Hughes B, Roubenoff R. The effect of progressive resistance training in rheumatoid arthritis. Increased strength without changes in energy balance or body composition. Arthritis Rheum. 1996; 39:415–26.
   PubMed Web of Science ®Google Scholar
• Pu CT, Johnson MT, Forman DE, Hausdorff JM, Roubenoff R, Foldvari M, et al. Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol. 2001; 90:2341–50.
   PubMed Web of Science ®Google Scholar
• Sullivan DH, Wall PT, Bariola JR, Bopp MM, Frost YM. Progres-sive resistance muscle strength training of hospitalized frail elderly. Am J Phys Med Rehabil. 2001; 80: 503–9.
   PubMed Web of Science ®Google Scholar
• Hauer K, Specht N, Schuler M, Bartsch P, Oster P. Intensive physical training in geriatric patients after severe falls and hip surgery. Age Ageing. 2002; 31:49–57.
   PubMed Web of Science ®Google Scholar
• Lemmer JT, Hurlbut DE, Martel GF, Tracy BL, Ivey FM, Metter EJ, et al. Age and gender responses to strength training and detraining. Med Sci Sports Exerc. 2000; 32: 1505–12.
   PubMed Web of Science ®Google Scholar
• Hakkinen K, Alen M, Kallinen M, Newton RU, Kraemer WJ. Neuromuscular adaptation during prolonged strength train-ing, detraining and re-strength-training in middle-aged and elderly people. EurJAppl Physiol. 2000; 83:51–62.
   PubMed Web of Science ®Google Scholar
• Taaffe DR, Marcus R. Dynamic muscle strength alterations to detraining and retraining in elderly men. Clin Physiol. 1997; 17: 311–24.
   PubMedGoogle Scholar
• Trappe S, Williamson D, Godard M. Maintenance of whole muscle strength and size following resistance training in old-er men. J Gerontol A Biol Sci Med Sci. 2002; 57: B138–43.
   Web of Science ®Google Scholar
• Kallinen M, Sipila S, Alen M, Suominen H. Improving cardio-vascular fitness by strength or endurance training in women aged 76–78 years. A population-based, randomized controlled trial. Age Ageing. 2002; 31: 247–54.
   Google Scholar
• Bautmans I, Lambert M, Mets T. The six-minute walk test in community dwelling elderly: influence of health status. BMC Geriatr. 2004; 4: 6.
   PubMedGoogle Scholar
• Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, et al. Exercise training and nutritional supple-mentation for physical frailty in very elderly people. The New England journal of medicine. 1994; 330:1769–75.
   PubMed Web of Science ®Google Scholar
• Fujita S, Volpi E. Nutrition and sarcopenia of ageing. Nutrition research reviews. 2004; 17: 69–76.
   Web of Science ®Google Scholar
• Dreyer HC, Volpi E. Role of protein and amino acids in the pathophysiology and treatment of sarcopenia. Journal of the American College of Nutrition. 2005; 24: 1405–55.
   Google Scholar
• Drummond MJ, Dreyer HC, Pennings B, Fry CS, Dhanani S, Dillon EL, et al. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. JApp(Physiol. 2008; 104: 1452–61.
   Google Scholar
• Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ. 2005; 330: 524–6.
   PubMed Web of Science ®Google Scholar
• Frisoli A, Jr., Chaves PH, Pinheiro MM, Szejnfeld VL. The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteopo-rosis: a double-blind, randomized, placebo-controlled clinical trial. The journals of gerontology. 2005; 60:648–53.
   Google Scholar
• Creutzberg EC, Wouters EF, Mostert R, Pluymers RJ, Schols AM. A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest. 2003; 124: 1733–42.
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproduc-tive Medicine Treatment of androgen deficiency in the aging male. Fertility and sterility. 2006; 86: 5236–40.
   Google Scholar
• Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerclioff RS, et al Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2006; 91: 1995–2010.
   PubMed Web of Science ®Google Scholar
• Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedi-cal issue. Proceedings of the NationalAcademy of Sciences of the United States of America. 2000; 97:4279–84.
   PubMed Web of Science ®Google Scholar
• Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men. The New England journal of medicine. 2006; 355: 1647–59.
   PubMed Web of Science ®Google Scholar
• Giovannini S, Marzetti E, Borst SE, Leeuwenburgh C. Modu-lation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults. Mechanisms of ageing and devel-opment. 2008; 129: 593–601.
   PubMed Web of Science ®Google Scholar
• Onder G, Penninx BW, Balkrishnan R, Fried LP, Chaves PH, Wil-liamson J, et al. Relation between use of angiotensin-convert-ing enzyme inhibitors and muscle strength and physical func-tion in older women: an observational study. Lancet. 2002; 359: 926–30.
   PubMed Web of Science ®Google Scholar
• Sumukadas D, Struthers AD, McMurdo ME. Sarcopenia--a po-tential target for Angiotensin-converting enzyme inhibition? Gerontology. 2006; 52: 237–42.
   Web of Science ®Google Scholar
• Jorgensen SB, Jensen TE, Richter EA. Role of AMPK in skeletal muscle gene adaptation in relation to exercise. Appl Physiol Nutr Metab. 2007; 32: 904–11.
   PubMed Web of Science ®Google Scholar
• Narkar VA, Downes M, Yu RI, Embler E, Wang YX, Banayo E, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell. 2008; 134: 405–15.
   PubMed Web of Science ®Google Scholar
• lannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. ] Gerontol A BiolSci Med Sci. 2002; 57: M772–7.
   Web of Science ®Google Scholar
• Tanko LB, Movsesyan L, Mouritzen U, Christiansen C, Svend-sen OL. Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women. Metabolism. 2002; 51:69–74.
   Web of Science ®Google Scholar
• Rolland Y, Lauwers-Cances V, Cournot M, Nourhashemi F, Reynish W, Riviere D, et al. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study.] Am Geriatr Soc. 2003; 51: 1120–4.
   PubMed Web of Science ®Google Scholar
• Gillette-Guyonnet S, Nourhashemi F, Andrieu S, Cantet C Al-baredej L, Vellas B, et al. Body composition in French women 75+ years of age: The EPIDOS study. Mechanisms of Ageing and Development. 2003; 124:311–6.
   Web of Science ®Google Scholar
• Kenny AM, Dawson L, Kleppinger A, lannuzzi-Sucich M, Judge JO. Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estro-gen-replacement thera py. J Gerontol A Biol Sci Med Sci. 2003; 58: M436–40.
   Web of Science ®Google Scholar
• Erratum to article by: Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard D, Barrett-Connor E. Sar-copenia in elderly men and women: The Rancho Bernardo Study: Am J Prey Med 2003;25:226-31. American Journal of Preventive Medicine. 2004; 27: 265–.
   Web of Science ®Google Scholar
• Pichard C, Kyle UG, Bracco D, Slosman DO, Morabia A, Schutz Y. Reference values of fat-free and fat masses by bioelectrical impedance analysis in 3393 healthy subjects. Nutrition. 2000; 16: 245–54.
   PubMed Web of Science ®Google Scholar
• Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, et al. Sarcopenia: alternative definitions and as-sociations with lower extremity function. J Am Geriatr Soc. 2003; 51: 1602–9.
   PubMed Web of Science ®Google Scholar
• Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physi-cal disability risk in older men and women. American journal of epidemiology. 2004; 159:413–21.
   PubMed Web of Science ®Google Scholar
• Lau EMC, Lynn HSH, Woo JW, Kwok ICY, Melton LJ, III. Preva-lence of and Risk Factors for Sarcopenia in Elderly Chinese Men and Women.] Gerontol A Biol Sci Med Sci. 2005; 60: 213–6.
   PubMed Web of Science ®Google Scholar
• Foley RN, Wang C, Ishani A, Collins AJ, Murray AM. Kidney function and sarcopenia in the United States general popula-tion: NHANES III. American journal of nephrology. 2007; 27: 279–86.
   PubMed Web of Science ®Google Scholar
• Gallagher D, Visser M, De Meersman RE, Sepulveda D, Baum-gartner RN, Pierson RN, et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol. 1997; 83: 229–39.
   PubMed Web of Science ®Google Scholar
• Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott AM, Hausherr E, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996; 348:145–9.
   PubMed Web of Science ®Google Scholar
• Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, et al. Admission criteria for immunogerontologi-cal studies in man: the SENIEUR protocol. Mech Ageing Dev. 1984; 28:47–55.
   PubMed Web of Science ®Google Scholar